Monaco Asset Management SAM Has $3.98 Million Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Key Points

• Monaco Asset Management SAM increased its stake in Teladoc Health by 22%, acquiring an additional 90,000 shares, bringing their total holdings to 500,000 shares worth approximately $3.98 million.
• Institutional investors own 76.82% of Teladoc Health's stock, indicating strong institutional interest with several firms significantly increasing their positions in the first quarter.
• Teladoc Health's stock has seen a decline of 8.1%, currently trading at $7.54, with analysts providing a mixed outlook, suggesting a target price range between $7.00 and $9.67.

Monaco Asset Management SAM raised its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 22.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 500,000 shares of the health services provider's stock after buying an additional 90,000 shares during the quarter. Teladoc Health accounts for about 0.8% of Monaco Asset Management SAM's portfolio, making the stock its 13th largest position. Monaco Asset Management SAM owned approximately 0.29% of Teladoc Health worth $3,980,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in TDOC. Cambridge Investment Research Advisors Inc. raised its position in shares of Teladoc Health by 60.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock worth $316,000 after purchasing an additional 15,030 shares during the period. Golden State Wealth Management LLC raised its position in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock worth $27,000 after purchasing an additional 1,690 shares during the period. Wedmont Private Capital raised its position in shares of Teladoc Health by 20.3% during the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock worth $117,000 after purchasing an additional 2,715 shares during the period. Geode Capital Management LLC grew its holdings in shares of Teladoc Health by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after buying an additional 22,664 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of Teladoc Health by 22.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock worth $134,000 after buying an additional 2,662 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of research reports. Mizuho initiated coverage on Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 price objective for the company. Stifel Nicolaus decreased their price objective on Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a report on Thursday, May 1st. Canaccord Genuity Group decreased their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Jefferies Financial Group decreased their price objective on Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a report on Monday, April 21st. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Thirteen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, Teladoc Health has an average rating of "Hold" and a consensus target price of $9.67.

Teladoc Health Stock Performance

Shares of NYSE TDOC traded down $0.27 during midday trading on Friday, hitting $6.94. 8,689,573 shares of the company's stock were exchanged, compared to its average volume of 7,300,037. The company has a quick ratio of 1.64, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The company's 50 day moving average price is $7.70 and its 200 day moving average price is $8.50. The firm has a market capitalization of $1.23 billion, a PE ratio of -5.83 and a beta of 1.76.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. The firm's revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period last year, the firm posted ($0.38) EPS. As a group, analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the sale, the insider directly owned 69,773 shares of the company's stock, valued at approximately $478,642.78. This trade represents a 7.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the sale, the insider directly owned 17,645 shares of the company's stock, valued at approximately $121,044.70. The trade was a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 18,656 shares of company stock valued at $128,189. Insiders own 0.58% of the company's stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.